Physician Profile
Naveen K. Yarlagadda, MD is a healthcare provider in Little Rock, AR specializing in hematology/oncology. Naveen is also listed as specializing in hematology & oncology. Medicare claims data shows Naveen provided 89,400 services to 2,661 patients. The services billed most often include injection, nivolumab, 1 mg, injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram, and injection, pembrolizumab, 1 mg. This provider record is associated with NPI 1396013363.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
8901 CARTI WAY
Little Rock, AR 72205
Within Hematology and Oncology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Advanced Cancers
Blood & Lymph Disorders
Blood Cancers
Blood Disorders
Blood disorders
Bone & Soft Tissue Cancers
Digestive Cancers
Endocrine Cancers
Endocrine tumors
Gastrointestinal cancer
General oncology
Genetic Blood Disorders
Gynecologic cancer
Gynecologic Cancers
Head & Neck Cancers
Head and neck cancer
Neurologic Cancers
Oncologic emergencies
Ophthalmologic oncology
Skin cancer
Skin Cancers
Urologic Cancers
Most searched procedures
Biopsies & Diagnostics
Blood disorder care
Cancer Therapies
Cancer therapy
Cellular Therapies
Consultations
Diagnostic testing
Hematology Treatments
Imaging
Infusions
Interventional oncology
Supportive Cancer Care
Supportive cancer care
Surgical & Vascular Access
Testing & Genetics
Vascular access care
89,400 services · 2,661 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
1,552 | More often than most peers in Hematology/Oncology |
| Injection of additional new drug or substance into vein | Treatment | 96375 |
655 | More than most peers in Hematology/Oncology |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
382 | More often than most peers in Hematology/Oncology |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
368 | More often than most peers in Hematology/Oncology |
| Injection, nivolumab, 1 mg | Drug given | J9299 |
21,760 | More often than most peers in Hematology/Oncology |
| Injection, pembrolizumab, 1 mg | Drug given | J9271 |
10,000 | As often as other peers in Hematology/Oncology |
| Injection, ferric derisomaltose, 10 mg | Drug given | J1437 |
9,700 | More than most peers in Hematology/Oncology |
| Injection, aprepitant, 1 mg | Drug given | J0185 |
5,850 | As often as other peers in Hematology/Oncology |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | Drug given | J0885 |
3,488 | As often as other peers in Hematology/Oncology |
| Injection, dexamethasone sodium phosphate, 1 mg | Drug given | J1100 |
3,195 | More often than most peers in Hematology/Oncology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Dr. Yarlagadda is a hematology/oncology in Little Rock, AR. That is the designation recorded for this NPI in the federal registry.
NPI registry
Dr. Yarlagadda is listed at 8901 Carti Way, Little Rock, AR 72205. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (501) 906-3000. Contact the office directly to confirm availability and scheduling.
NPI registry
Dr. Yarlagadda's National Provider Identifier is 1396013363. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Dr. Yarlagadda attended Other, graduating in 2007. This comes from the CMS National Downloadable File.
CMS public data
Dr. Yarlagadda has 19 years experience. Calculated from a graduation year of 2007, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Dr. Yarlagadda performs procedures including insertion of needle into vein for collection of blood sample; provides treatments such as injection of additional new drug or substance into vein and injection of drug or substance under skin or into muscle, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Dr. Yarlagadda. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.